Innovations in translational gender-sensitive medication development for tobacco dependence

Join a seminar: “Innovations in Translational Gender-Sensitive Medication Development for Tobacco Dependence.”

Date: April 6, 2017
Time: 4:00-5:30 PM
Location: Bell Gateway Building, 100 Stokes Street, Room 3158.

Learning objectives:

  • Describe significant health disparities faced by women smokers
  • List factors associated with poor smoking cessation treatment response for women
  • Discuss options for gender-informed approaches for smoking cessation

The presenter:

Sherry McKee, PhD, Professor of Psychiatry, Director of the Yale Behavioral Pharmacology Laboratory, Director of the Forensic Drug Diversion Clinic, Yale School of Medicine

Dr. Sherry McKee received her PhD in clinical psychology from the University of Western Ontario and is currently a Professor of Psychiatry at Yale School of Medicine. Dr. McKee ’s research over the past 20 years has been directed at developing effective treatments for addiction, with a particular focus on women and more recently, criminal justice populations. Her translational work spans human laboratory paradigms, clinical trials, survey research, and epidemiological research to uncover the mechanisms underlying poor outcomes and to translate these findings into improved interventions. Dr. McKee’s research achievements have been recognized by the Natural Sciences and Engineering Research Council of Canada, Research Society for Alcoholism, National Institute on Drug Abuse, Society for Research on Nicotine and Tobacco, the National Alliance for Research on Schizophrenia and Depression, and the American Psychological Association.